Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea.
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
A profile of childhood neuropathies at a university hospital in Oman.
White matter disease: Longest follow-up of rituximab for neuromyelitis optica.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Is there a cognitive signature for MS-related fatigue?
Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
"I knew what was going to happen if I did nothing and so I was going to do something": Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek unproven interventions abroad.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
Transverse Myelitis.
Month of birth is not a definite risk factor for multiple sclerosis.
The Multiple Sclerosis-Fatigue Self- Efficacy (MS-FSE) scale: initial validation.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.

Pages